Literature DB >> 17475995

Congenital rubella syndrome in a child born to Liberian refugees: clinical and public health perspectives.

Rachel N Plotinsky1, Elizabeth A Talbot, Joan E Kellenberg, Susan E Reef, Sandra K Buseman, Karen D Wright, John F Modlin.   

Abstract

We describe a case of congenital rubella syndrome with typical stigmata in an infant born in New Hampshire to Liberian refugees. The infant's clinical specimens were tested for rubella. Rubella immunity status was sought for contacts. The infant's specimen cultures grew wild-type rubella virus; serum immunoglobulin M and G were positive. Eighteen of 20 contacts were rubella-immune. Family's transit history, mother's vaccination history, and infant's estimated gestational age supported congenital infection acquired overseas. Clinicians should maintain vigilance for congenital rubella syndrome in infants with relevant stigmata, particularly those whose mothers are from countries with nonexistent or recently implemented rubella vaccination programs.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17475995     DOI: 10.1177/0009922806293915

Source DB:  PubMed          Journal:  Clin Pediatr (Phila)        ISSN: 0009-9228            Impact factor:   1.168


  3 in total

Review 1.  Post-exposure passive immunisation for preventing rubella and congenital rubella syndrome.

Authors:  Megan K Young; Allan W Cripps; Graeme R Nimmo; Mieke L van Driel
Journal:  Cochrane Database Syst Rev       Date:  2015-09-09

2.  Evaluation of rubella immunity in a community prenatal clinic.

Authors:  Edward C Nwanegbo; Thor Swanson; Oluseyi Vanderpuye; Carlos F Rios-Bedoya
Journal:  ISRN Family Med       Date:  2013-01-15

3.  Pregnancy Related Health Care Needs in Refugees-A Current Three Center Experience in Europe.

Authors:  Christian Dopfer; Annabelle Vakilzadeh; Christine Happle; Evelyn Kleinert; Frank Müller; Diana Ernst; Reinhold E Schmidt; Georg M N Behrens; Sonja Merkesdal; Martin Wetzke; Alexandra Jablonka
Journal:  Int J Environ Res Public Health       Date:  2018-09-05       Impact factor: 3.390

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.